Skip to main content

PharmChallenge #3

REverse COnceptual Product Engineering (RECOPE)

PharmChallenge #3:

Improving Care and Treatment in Epilepsy

Epilepsy is the fourth most common neurological disorder in the United states, affecting 2.3 million adults and 480,000 children. According to the centers of disease prevention and control, the US economic burden related to epilepsy is about $15.5 billion.

 

A payer’s perspective on the opportunities around epilepsy treatment can be found here:

http://www.amcp.org/ManagedCareIntegratedCareSummitOnEpilepsy-Findings/